bosentan anhydrous has been researched along with Lung Diseases in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gómez-Meda, BC; Lemus-Varela, Mde L; Melnikov, V; Ornelas-Aguirre, JM; Soliz, A; Torres-Mendoza, BM; Zamora-Perez, AL; Zúñiga-González, GM | 1 |
| Gialafos, EJ; Moyssakis, I; Sfikakis, PP; Taktikou, H; Voteas, V | 1 |
| Andersson, SE; Hemsén, A; Lundberg, JM | 1 |
3 other study(ies) available for bosentan anhydrous and Lung Diseases
| Article | Year |
|---|---|
Antenatal use of bosentan and/or sildenafil attenuates pulmonary features in rats with congenital diaphragmatic hernia.
Topics: Animals; Bosentan; Disease Models, Animal; Female; Hernias, Diaphragmatic, Congenital; Lung; Lung Diseases; Phenyl Ethers; Piperazines; Pregnancy; Purines; Random Allocation; Rats; Rats, Wistar; Sildenafil Citrate; Sulfonamides; Vascular Remodeling | 2014 |
Treatment of pulmonary hypertension secondary to alveolar microlithiasis with Bosentan: a case report.
Topics: Antihypertensive Agents; Bosentan; Female; Humans; Hypertension, Pulmonary; Lithiasis; Lung Diseases; Middle Aged; Sulfonamides | 2005 |
The effect of endothelin receptor blockade on the development of the Sephadex-induced inflammation in the rat lung.
Topics: Animals; Bosentan; Dextrans; Endothelin Receptor Antagonists; Inflammation; Lung; Lung Diseases; Male; Rats; Rats, Sprague-Dawley; Sulfonamides | 1996 |